×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
SusceptibilityMutation
disease
CLINVAR
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.
23571587
2013
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
SusceptibilityMutation
disease
CLINVAR
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
23296339
2013
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
Mutations in the PSEN1, PSEN2, and APP genes seem to be rare in this population, as these genes exhibited no pathogenic mutations in our cohort of eoAD and FTLD patients even though about 40% of the cases were familial ones.
21959359
2013
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
CLINVAR
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.
23224319
2013
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms.
23827522
2013
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
Biomarker
disease
CTD_human
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
24162737
2013
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
SusceptibilityMutation
disease
CLINVAR
APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.
23060451
2012
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
This is true for HTT, the β-amyloid precursor protein (APP ) and presenilins, responsible for early onset Alzheimer's disease (AD ).
22489754
2012
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model.
22507317
2012
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
SusceptibilityMutation
disease
CLINVAR
Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis.
22381401
2012
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
Familial forms of CAA are because of mutations in the gene encoding the beta-amyloid precursor protein (APP ) and duplications of this gene can cause early-onset Alzheimer's disease associated with CAA.
21463452
2011
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
21980910
2011
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
GeneticVariation
disease
BEFREE
Retrospective review of clinical data (age at onset, family history, clinical presentation, diagnostic delay, diagnosis) and APOE genotype of patients with neuropathologically confirmed EOAD (<60 years).
21576687
2011
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
AlteredExpression
disease
BEFREE
We analyzed genome-wide interplay between promoter CpG DNA methylation and gene expression in an APP-sw -expressing AD model cell line.
22001921
2011
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
21157020
2011
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
Mutations in the beta-amyloid precursor protein gene (APP) have been found in familial early-onset Alzheímer's disease (AD ).
21424791
2011
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.500
GeneticVariation
disease
BEFREE
Conversely, patients negative for the APOE ɛ4 allele and with early-onset AD are more likely to be predisposed to vulnerability of cerebral networks beyond the medial temporal lobes.
21185234
2011
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
AlteredExpression
disease
BEFREE
Taken together, we propose that the expression of APP-swe modulates global gene expression directed to AD pathogenesis.
21034535
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.
21209907
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
On the metal ion (Zn(2+), Cu(2+)) coordination with beta-amyloid peptide: DFT computational study.
20640797
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
Early-onset Alzheimer disease in this family was associated with a V717G mutation in the amyloid precursor protein gene (APP).
19950418
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity.
20111991
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
BEFREE
These findings strongly implicate APP and the betaCTF of APP , and exclude Abeta and the alphaCTF, as the cause of endocytic pathway dysfunction in DS and AD , underscoring the potential multifaceted value of BACE-1 inhibition in AD therapeutics.
20080541
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
GeneticVariation
disease
BEFREE
The London APP mutation (Val717Ile ) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease .
20523046
2010
×
Entrez Id:
351
Gene Symbol:
APP
APP
0.500
Biomarker
disease
CTD_human
Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices.
20157255
2010